In a sign of just how tough the funding environment has become for the biotech industry, Singapore’s Tessa Therapeutics has pulled stumps after failing to raise more capital to advance its next generation cell therapy ambitions.
https://www.fiercebiotech.com/biotech/tessa-therapeutics-dissolves-after-raising-more-200m
https://www.geneonline.com/singapore-tessa-therapeutics-announces-liquidation/
In a sign of just how tough the funding environment has become...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $30.60M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.8¢ | $47.91K | 1.256M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 881755 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 150000 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PTX (ASX) Chart |